Education
About Us
Working with TipRanks
Follow Us
Surgery Partners Inc (SGRY)
NASDAQ:SGRY
Total Valuation
Surgery Partners has a market cap or net worth of $2.88B. The enterprise value is $7.95B.
Market Cap$2.88B
Enterprise Value$7.95B
Share Statistics
Surgery Partners has 128,192,730 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding128,192,730
Owned by Insiders1.39%
Owned by Institutions1.02%
Financial Efficiency
Surgery Partners’s return on equity (ROE) is -0.09 and return on invested capital (ROIC) is 0.40%.
Return on Equity (ROE)-0.09
Return on Assets (ROA)-0.02
Return on Invested Capital (ROIC)0.40%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee207.62K
Profits Per Employee833.33
Employee Count15,000
Asset Turnover0.39
Inventory Turnover26.80
Valuation Ratios
The current PE Ratio of Surgery Partners is -15.88. Surgery Partners’s PEG ratio is -0.01.
PE Ratio-15.88
PS Ratio0.00
PB Ratio1.49
Price to Fair Value1.49
Price to FCF12.73
Price to Operating Cash Flow8.90
PEG Ratio-0.01
Income Statement
In the last 12 months, Surgery Partners had revenue of 3.11B and earned -168.10M in profits. Earnings per share was -1.33.
Revenue3.11B
Gross Profit745.60M
Operating Income348.80M
Pretax Income147.10M
Net Income-168.10M
EBITDA501.40M
Earnings Per Share (EPS)-1.33
Cash Flow
In the last 12 months, operating cash flow was 300.10M and capital expenditures -90.40M, giving a free cash flow of 209.70M billion.
Operating Cash Flow300.10M
Free Cash Flow209.70M
Free Cash Flow per Share1.64
Dividends & Yields
Surgery Partners pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.33
52-Week Price Change-10.28%
50-Day Moving Average23.12
200-Day Moving Average26.12
Relative Strength Index (RSI)49.42
Average Volume (3m)975.76K
Important Dates
Surgery Partners upcoming earnings date is May 12, 2025, TBA Not Confirmed.
Last Earnings DateMar 3, 2025
Next Earnings DateMay 12, 2025
Ex-Dividend Date―
Financial Position
Surgery Partners as a current ratio of 1.79, with Debt / Equity ratio of 206.93%
Current Ratio1.79
Quick Ratio1.65
Debt to Market Cap0.15
Net Debt to EBITDA0.25
Interest Coverage Ratio1.73
Taxes
In the past 12 months, Surgery Partners has paid 134.60M in taxes.
Income Tax134.60M
Effective Tax Rate0.92
Enterprise Valuation
Surgery Partners EV to EBITDA ratio is 5.57, with an EV/FCF ratio of 13.32.
EV to Sales0.90
EV to EBITDA5.57
EV to Free Cash Flow13.32
EV to Operating Cash Flow9.31
Balance Sheet
Surgery Partners has $269.50M in cash and marketable securities with $1.41B in debt, giving a net cash position of $3.43B billion.
Cash & Marketable Securities$269.50M
Total Debt$1.41B
Net Cash$3.43B
Net Cash Per Share$26.79
Tangible Book Value Per Share-$11.72
Margins
Gross margin is 22.86%, with operating margin of 11.20%, and net profit margin of -5.40%.
Gross Margin22.86%
Operating Margin11.20%
Pretax Margin4.72%
Net Profit Margin-5.40%
EBITDA Margin16.10%
EBIT Margin11.20%
Analyst Forecast
The average price target for Surgery Partners is $32.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$32.00
Price Target Upside42.67% Upside
Analyst ConsensusStrong Buy
Analyst Count10
Revenue Growth Forecast13.52%
EPS Growth Forecast-1296.44%